![Frontiers | Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis Frontiers | Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis](https://www.frontiersin.org/files/Articles/999822/fonc-12-999822-HTML/image_m/fonc-12-999822-g001.jpg)
Frontiers | Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis
![A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia | Leukemia A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-019-0604-8/MediaObjects/41375_2019_604_Fig1_HTML.png)
A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia | Leukemia
![PDF) The Weekend School Effect on Perceived Cognitive and Social Competences: Evidence from a Randomized Controlled Experiment PDF) The Weekend School Effect on Perceived Cognitive and Social Competences: Evidence from a Randomized Controlled Experiment](https://i1.rgstatic.net/publication/241767724_The_Weekend_School_Effect_on_Perceived_Cognitive_and_Social_Competences_Evidence_from_a_Randomized_Controlled_Experiment/links/00b49529f9cf4ce58e000000/largepreview.png)
PDF) The Weekend School Effect on Perceived Cognitive and Social Competences: Evidence from a Randomized Controlled Experiment
![The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed - Bakunina - 2022 - Cancer Medicine - Wiley Online Library The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed - Bakunina - 2022 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/96b0b516-af4d-4dd1-80c7-9e0f93100437/cam44392-fig-0005-m.jpg)
The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed - Bakunina - 2022 - Cancer Medicine - Wiley Online Library
![Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS - ScienceDirect Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S247395292031507X-grabsf1.jpg)
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS - ScienceDirect
![Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka](https://cyberleninka.org/viewer_images/1086573/f/1.png)
Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka
![Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML - ScienceDirect Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952920318802-fx1.jpg)
Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML - ScienceDirect
![Cancers | Free Full-Text | Real-World Experience of Measurable Residual Disease Response and Prognosis in Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine Cancers | Free Full-Text | Real-World Experience of Measurable Residual Disease Response and Prognosis in Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine](https://pub.mdpi-res.com/cancers/cancers-14-03576/article_deploy/html/images/cancers-14-03576-g002.png?1658825848)